US1050299A - Process of producing a remedy for tuberculosis. - Google Patents

Process of producing a remedy for tuberculosis. Download PDF

Info

Publication number
US1050299A
US1050299A US651401A US1911651401A US1050299A US 1050299 A US1050299 A US 1050299A US 651401 A US651401 A US 651401A US 1911651401 A US1911651401 A US 1911651401A US 1050299 A US1050299 A US 1050299A
Authority
US
United States
Prior art keywords
remedy
tuberculosis
serum
bacilli
tubercle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US651401A
Inventor
Wilhelm Ruppel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US57263810A external-priority patent/US1037997A/en
Application filed by Hoechst AG filed Critical Hoechst AG
Priority to US651401A priority Critical patent/US1050299A/en
Application granted granted Critical
Publication of US1050299A publication Critical patent/US1050299A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1289—Mycobacteriaceae (F)

Definitions

  • tubercle-bacilli are loaded With the serum, whereby combination of the immune bodies -t v'tnh tnberclwliacillitakes place 'loetnat etlect.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Description

vextracted.
WILHELM RUPPEL, OF Ht jCHST-ONTHE-M AI-N.
GERMANY, ASSIGNOR TC FARBWERKE VORM. MEISTER-LUCIUS 8c BBUNING. 0F HGCHST-ON-THEMAIN, GERMANY; A Q011- PORATION OF (SiEIiJlIIANY. I
PROCESS OF 1.?RODUCING A REMEDY FOR TUBERCULOSIS.
Specification of Letters Patent.
Patented Jan. 14,1913.
No Drawing. Original application filed July 18, 1910, Serial No. 572,638. Divided and this application tiled September 26, 1911. Serial No 651.401.
'1}; all IF/IO/it it may conccrn:
Be it known that I, 'lVl'L-i-mrn R'UPPBL, Ph. D. and professor of medicine a citizen of the Empire of Germany, residing at Hiichst-on-tbe-l[aim Prussia,of the Empire of Germany, have invented certain new and useful Improvements in Processes of Pro-a dncing a Remedy for Tubercplosis, of which the following is a specification.
Specific all lltltbQl'cLllOSlS-SEIUIU. such as for instance that. obtained according to my U. S. patent application Serv No. 572,638, tiled July 18, l9 it), contains nnmune' bodies which act on tnberclobacilli and other preparations derived therefrom. As the treatment of tuberculosis in the St rum-tl'ierapcutical, way always oti'ers 'ditlitulties by complications arising in the incorporation of albumins. it. seemed advisable toisolate the immune bodies from the serum. In this respect tubercle-bacilli are loaded With the serum, whereby combination of the immune bodies -t v'tnh tnberclwliacillitakes place 'loetnat etlect. it was first ascertaine'cFby the usual methids what amount of the various specific immune bodies were contained in theantitubereulosis-sernm tobe pose it is sullicient to determine as exactly as possible the agglutinatingpower of the serum and to find by calculation the quanlily of serum lVlllt'll is able to act on a (ten taiu amonut of tubercle-lau-illi. Thus. for instance, we proceed as follows: 1 gr. of
completiagglutination of the said quantity" of lullel't'ltklltltilllh, if, for instance, 0.003
gr. of this tnlmrclmbacilli are completely agglutinated by 0.0035 c. c. of serum, then corresponding quantities of tubercle-bacilli and antituberculosis'serum, preferably an excess of the latter, are used. for the preparation of the remedy. In a similar manner the amount of complementfixing sub it was found that for this pur stance, ops-onins or bacteriotropins contained lit the tlntlttibtIC1ll0SlS-SltlIll ascertained. Also by this preliminary test' the best combination of antitubereulo-' sis-serum and tuberclobacilli can be determined. The mixture of immune antitubercle-serum and tubercle-bacilli combined according to the foregoing preliminary. test are allowed to stand in an incubator at; 3725? C. for A to *8 hours. The bacilli are thereby loaded with immune bodies and rendered non-toxic. Then they are shaken together with glass beads in a' shaking apparatus urlzl no intact tubercledricilli can be microscopically detected. \Vhcn the llllbCl'ClC-btla Cllll are so far altered, they are separated from the superfluous serum by ccntrifugating. To thesetnberclobacilli physiological salt solution and glycerin. are added in the proportion of for instance, 121200, to form a fine emulsion. 'liuw emulsions of sensitized tubercle-bacilii are used as a. remedy for tuberculosis. It hae been proved that tuberculous patients stand injections thereof without any febrile reaction and obtain permanent improvemem'.
This application is a division of my specified prior one, Ser. No. 572,638.
Having thus described the nature of my invention what I claim is: V
The process of producing emulsions of sensitized tubercle-bacilli as a remedy for. tuberculosis, consisting in causing a specific antitnberculosisserum to act upon tubercle bacilli, so that the tubt t'tltdJtlCllll are ren" dered nontoxic and loaded with speciticin nuine bodies, shaking the mixture of sensitizcd tubercle-bacilli and serum for a long time with insoluble inert hard material in a shaking apparatus until the bacilli are pe fectly triturated, separating serum and bacilli by centrifugating. and mixing the isolated bacilli with suitable quantities of salt solution and glycerin, a as to form an opalescent milky liquid.
in testimony whereof, I altix my signature. in presence of two witnesses.
JEAN Grimm), CARL GRUND.
US651401A 1910-07-18 1911-09-26 Process of producing a remedy for tuberculosis. Expired - Lifetime US1050299A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US651401A US1050299A (en) 1910-07-18 1911-09-26 Process of producing a remedy for tuberculosis.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57263810A US1037997A (en) 1910-07-18 1910-07-18 Process of producing a remedy for tuberculosis.
US651401A US1050299A (en) 1910-07-18 1911-09-26 Process of producing a remedy for tuberculosis.

Publications (1)

Publication Number Publication Date
US1050299A true US1050299A (en) 1913-01-14

Family

ID=3118564

Family Applications (1)

Application Number Title Priority Date Filing Date
US651401A Expired - Lifetime US1050299A (en) 1910-07-18 1911-09-26 Process of producing a remedy for tuberculosis.

Country Status (1)

Country Link
US (1) US1050299A (en)

Similar Documents

Publication Publication Date Title
Marler et al. The polypeptide chains of rabbit γ-globulin and its papain-cleaved fragments
Alexander Foetal'Antigens' in Cancer.
Cohn The separation of blood into fractions of therapeutic value
Kleinman et al. Studies of colonic carcinoma antigens
Simpkins et al. Changes in the molecular structure of axonal and red blood cell membranes following treatment with phospholipase A2
Kowlessar et al. Localization of 5-nucleotidase and non-specific alkaline phosphatase by starch gel electrophoresis
Zopf et al. Goat antibody directed against a human Leb blood group hapten, lacto-N-difucohexaose I
von Wechmar et al. Serological studies on bromegrass mosaic virus and its protein fragments
CA1077393A (en) Antihemophilic agent and process for its manufacture
Becker et al. Crystallographic studies of bovine beta2-microglobulin.
García-Montoya et al. Sticholysin recognition of ceramide-phosphoethanolamine
Partridge et al. Immunization experiments with artificial complexes formed from substances isolated from the antigen of Bact. shigae
Fiset in vitro: Non-Precipitating Rabbit Antibodies: A Study of their Reactivity: by Means of the Quantitative Precipitin and Tannic Acid Haemagglutination Techniques
Pope et al. The properties of crystalline diphtheria toxin-protein: its antigen composition as determined by gel-diffusion methods
Schultz et al. The influence of methylcholanthrene on serum protein synthesis in the rat
Graham XXXV.—On liquid diffusion applied to analysis
US588230A (en) Process of generating gas from carbids
US2275623A (en) Medicinal preparation
US402494A (en) Sabbati e
Yamada et al. The correlation between plasma cell tumor development and antibody response in inbred strains of mice
US1534832A (en) Process for producing a remedy for syphilis
US778783A (en) Process of producing a nutritive substance from blood.
GENGOU LA THEORIE PHYSIQUE DE L'IMMUNITÉ ET SES BASES EXPÉRIMENTALES/THE PHYSICAL THEORY OF IMMUNITY AND ITS EXPERIMENTAL BASES (Continued)
US746688A (en) Substance resembling india-rubber.
Crowle et al. Antigen-antibody precipitation contrasted in gels of high and physiological salt concentrations